SG3 Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

SG3 Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-33,600	Closed	-$572K	–	1590
2020 Q4	$572K	Buy	33,600 +3,600	+12%	+$45.1K	0.01%	700
2020 Q3	$141K	Buy	+30,000	New	+$152K	0.01%	767

SG3 Management's FPRX Position: Q2 2021 in Review

SG3 Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 10,000 shares — an estimated $377K sold.

SG3 Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $377K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

SG3 Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
SG3 Management sold 10,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $377K.
SG3 Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
SG3 Management's Five Prime Therapeutics, Inc. position peaked at $377K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.